For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.
LPI (LP Information)' newest research report, the "Neuromodulation Devices and Implantable Infusion Pumps Industry Forecast" looks at past sales and reviews total world Neuromodulation Devices and Implantable Infusion Pumps sales in 2022, providing a comprehensive analysis by region and market sector of projected Neuromodulation Devices and Implantable Infusion Pumps sales for 2023 through 2029. With Neuromodulation Devices and Implantable Infusion Pumps sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neuromodulation Devices and Implantable Infusion Pumps industry.
This Insight Report provides a comprehensive analysis of the global Neuromodulation Devices and Implantable Infusion Pumps landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neuromodulation Devices and Implantable Infusion Pumps portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Neuromodulation Devices and Implantable Infusion Pumps market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neuromodulation Devices and Implantable Infusion Pumps and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neuromodulation Devices and Implantable Infusion Pumps.
The global Neuromodulation Devices and Implantable Infusion Pumps market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
In United States, Neuromodulation Devices and Implantable Infusion Pumps key players include Medtronic, Boston Scientific Corporation, St. Jude Medical, etc. Global top three manufacturers hold a share over 75%.
Midwest is the largest market, with a share about 50%, followed by South, and West, both have a share over 45 percent.
In terms of product, Spinal Cord Stimulation is the largest segment, with a share over 50%. And in terms of application, the largest application is Pain, followed by Parkinson's disease, Epilepsy, etc.
This report presents a comprehensive overview, market shares, and growth opportunities of Neuromodulation Devices and Implantable Infusion Pumps market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Vagal Nerve Stimulation
- Gastric Stimulation
- Transcranial Magnetic Stimulation
- Transcutaneous Electrical Stimulation
- Other
Segmentation by application
- Parkinson's Disease
- Epilepsy
- Pain
- Other
The below companies that are profiled
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- Medtronic
- Boston Scientific Corporation
- St. Jude Medical
- Synapse Biomedical
- Nevro Corporation
- Neuropace
- Cyberonics
- Autonomic Technologies
- Avery Biomedical
- Greatbatch Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Neuromodulation Devices and Implantable Infusion Pumps market?
What factors are driving Neuromodulation Devices and Implantable Infusion Pumps market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Neuromodulation Devices and Implantable Infusion Pumps market opportunities vary by end market size?
How does Neuromodulation Devices and Implantable Infusion Pumps break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?